These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21079206)

  • 1. ACP Journal Club. Review: Fibrates reduce risk for cardiovascular outcomes.
    Santos RD
    Ann Intern Med; 2010 Nov; 153(10):JC5-11. PubMed ID: 21079206
    [No Abstract]   [Full Text] [Related]  

  • 2. ACP Journal Club. Review: Statins reduce mortality and cardiovascular events in adults at risk for cardiovascular disease.
    Davidson RA; Rosenberg E
    Ann Intern Med; 2009 Oct; 151(8):JC4-14. PubMed ID: 19841451
    [No Abstract]   [Full Text] [Related]  

  • 3. ACP Journal Club. Review: Statins reduce mortality and cardiovascular (CV) morbidity in patients with low CV risk.
    Muñoz D; Granger CB
    Ann Intern Med; 2012 Apr; 156(8):JC4-07. PubMed ID: 22508747
    [No Abstract]   [Full Text] [Related]  

  • 4. ACP Journal Club. Review: rosiglitazone increases risk for cardiovascular outcomes and mortality compared with pioglitazone in type 2 diabetes.
    Deedwania P
    Ann Intern Med; 2011 Aug; 155(4):JC2-12. PubMed ID: 21844545
    [No Abstract]   [Full Text] [Related]  

  • 5. ACP Journal Club. Review: angiotensin-receptor blockers do not increase adverse cardiovascular outcomes.
    Halim SA; Newby LK
    Ann Intern Med; 2011 Aug; 155(4):JC2-2. PubMed ID: 21844535
    [No Abstract]   [Full Text] [Related]  

  • 6. ACP Journal Club. Review: omega-3 polyunsaturated fatty acid supplements do not reduce major cardiovascular events in adults.
    Smith DA
    Ann Intern Med; 2012 Dec; 157(12):JC6-5. PubMed ID: 23247954
    [No Abstract]   [Full Text] [Related]  

  • 7. ACP Journal Club. Review: General health checks in adults do not reduce all-cause, cardiovascular, or cancer mortality.
    Lim LS
    Ann Intern Med; 2013 Jan; 158(2):JC2. PubMed ID: 23318336
    [No Abstract]   [Full Text] [Related]  

  • 8. ACP Journal Club. Review: ACE-Is or ARBs reduce adverse CV outcomes regardless of baseline systolic blood pressure.
    Singh V
    Ann Intern Med; 2012 Jul; 157(2):JC2-8. PubMed ID: 22801699
    [No Abstract]   [Full Text] [Related]  

  • 9. ACP Journal Club. Review: ACE inhibitors reduce risk for pneumonia.
    Lipchik RJ
    Ann Intern Med; 2012 Nov; 157(10):JC5-2. PubMed ID: 23165678
    [No Abstract]   [Full Text] [Related]  

  • 10. ACP Journal Club. Review: Varenicline increases risk for serious adverse cardiovascular events in tobacco users.
    Brophy JM
    Ann Intern Med; 2011 Oct; 155(8):JC4-5. PubMed ID: 22007064
    [No Abstract]   [Full Text] [Related]  

  • 11. ACP Journal Club. Review: A Mediterranean diet reduces cardiovascular risk factors in overweight patients compared with a low-fat diet.
    Havranek EP
    Ann Intern Med; 2011 Dec; 155(12):JC6-3. PubMed ID: 22184704
    [No Abstract]   [Full Text] [Related]  

  • 12. ACP Journal Club. Review: Exercise/physical therapy and vitamin D each reduce risk for falls in older community-dwelling adults.
    Kiel DP
    Ann Intern Med; 2011 Apr; 154(8):JC4-5. PubMed ID: 21502643
    [No Abstract]   [Full Text] [Related]  

  • 13. ACP Journal Club. Review: Counseling and educational methods that target multiple CV risk factors do not reduce mortality in adults without CHD.
    Patel MJ; Newby LK
    Ann Intern Med; 2011 Jun; 154(12):JC6-4. PubMed ID: 21690582
    [No Abstract]   [Full Text] [Related]  

  • 14. ACP Journal Club: statins do not reduce mortality in patients with no history of cardiovascular disease.
    Ray KK
    Ann Intern Med; 2010 Sep; 153(6):JC3-4. PubMed ID: 20855793
    [No Abstract]   [Full Text] [Related]  

  • 15. ACP Journal Club. Review: Erythropoiesis-stimulating agents targeted to higher hemoglobin levels increase risk for adverse outcomes in CKD.
    Hsu CY
    Ann Intern Med; 2010 Nov; 153(10):JC5-3. PubMed ID: 21079210
    [No Abstract]   [Full Text] [Related]  

  • 16. ACP Journal Club. Review: Tamoxifen, raloxifene, and tibolone prevent primary invasive breast cancer but increase risk for adverse outcomes.
    Melnikow J
    Ann Intern Med; 2010 Mar; 152(6):JC3-4. PubMed ID: 20231558
    [No Abstract]   [Full Text] [Related]  

  • 17. ACP Journal Club. Review: Antihypertensive treatment prevents cardiovascular events and mortality in cardiovascular disease without hypertension.
    Cohn JN
    Ann Intern Med; 2011 Jun; 154(12):JC6-6. PubMed ID: 21690584
    [No Abstract]   [Full Text] [Related]  

  • 18. ACP Journal Club. Review: Inhaled anticholinergics increase risk for major cardiovascular events in chronic obstructive pulmonary disease.
    Stanbrook MB
    Ann Intern Med; 2009 Jan; 150(2):JC1-6, JC1-7. PubMed ID: 19172711
    [No Abstract]   [Full Text] [Related]  

  • 19. ACP Journal Club. Review: Interferon and nucleoside/tide analogues reduce risk for hepatocellular cancer in patients with chronic hepatitis B.
    Sherker AH
    Ann Intern Med; 2009 Apr; 150(8):JC4-11. PubMed ID: 19391225
    [No Abstract]   [Full Text] [Related]  

  • 20. ACP Journal Club. Novel risk markers improved Framingham Risk Score cardiovascular event prediction in intermediate-risk adults.
    Steinberg DI
    Ann Intern Med; 2012 Dec; 157(12):JC6-13. PubMed ID: 23247962
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.